Video

Q&A With Emmanuelle Waubant of UCSF: Treating Pediatric Multiple Sclerosis

Author(s):

Doctors treating patients with pediatric multiple sclerosis often turn to the same treatments as adult patients. While there are some unique characteristics and more work is being done in the field, these seem to give the best hope of maintaining a high quality of life for the young patients.

Doctors treating patients with pediatric multiple sclerosis often turn to the same treatments as adult patients. While there are some unique characteristics and more work is being done in the field, these seem to give the best hope of maintaining a high quality of life for the young patients.

Emmanuelle Waubant, MD, from the University of California at San Francisco discussed how treatment has advanced for these patients over the past decade and where the work is going for the future during the American Academy of Neurology's annual meeting in Washington DC.

Related Videos
Caroline Piatek, MD: High HCRU, Patient Concerns Highlight Great Unmet Need in wAIHA
Steven W. Pipe, MD: Supporting Gene Therapy Implementation for Hemophilia
Corinna L. Schultz, MD: Improving Sickle Cell Trait Documentation in Infancy
Sibgha Zaheer, MD: Determining Washout Period With Fitusiran, Emicizumab Transition for Hemophilia
Pavan K. (Tem) Bendapudi, MD: Large-Scale Analyses Elucidate Genetic Risk of Thrombosis
Seema Rani, MD: Examining Sleep Health in Youth With SCD
Daniel Wang: A More Appropriate Ferritin Threshold is Cost-Effective for Iron Deficiency Screening
Kimberly A. Davidow, MD: Elucidating Risk of Autoimmune Disease in Childhood Cancer Survivors
Yehuda Handelsman, MD: Insulin Resistance in Cardiometabolic Disease and DCRM 2.0 | Image Credit: TMIOA
© 2025 MJH Life Sciences

All rights reserved.